Allmed Medical Products Co.,Ltd (002950.SZ)
- Previous Close
8.07 - Open
8.08 - Bid 8.05 x --
- Ask 8.06 x --
- Day's Range
8.05 - 8.17 - 52 Week Range
6.12 - 10.52 - Volume
4,031,850 - Avg. Volume
7,236,676 - Market Cap (intraday)
5.098B - Beta (5Y Monthly) --
- PE Ratio (TTM)
13.88 - EPS (TTM)
0.58 - Earnings Date --
- Forward Dividend & Yield 0.03 (0.34%)
- Ex-Dividend Date Jun 19, 2024
- 1y Target Est
--
Allmed Medical Products Co.,Ltd engages in the manufacture and sale of wound care and nursing material products in China. The company's general wound care products include elastic and adhesive bandage, oil emulsion dressing, xeroform gauze dressing, non-woven and woven gauze swabs, fluffy bandages/sponges, abdominal pads, gauze/non-woven drain sponges, post-op sponges, eye pads, cotton filled exodontia sponges, non-stick pads, gauze balls /nonwoven balls, and petrolatum gauze dressing. It also provides OR/surgery products, including X-ray non-woven swabs, OR towels, laparotomy and neuro sponges, X-ray gauze swabs, and X-ray detectable gauze balls and nonwoven balls; medical kits; and patient care products comprising disposable nursing pads and disposable drapes, as well as particulate respirator. In addition, the company offers dry and wet, and alcohol and makeup remover wipes; surgical gowns, CSR wraps, and medical drapes; and isolation gowns, coverall, surgical cap and bouffant products, and shoe and boot covers. The company also exports its products. Allmed Medical Products Co.,Ltd was founded in 1992 and is based in Shenzhen, the People's Republic of China.
cn.allmed-china.comRecent News: 002950.SZ
View MorePerformance Overview: 002950.SZ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 002950.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 002950.SZ
View MoreValuation Measures
Market Cap
5.10B
Enterprise Value
4.94B
Trailing P/E
13.92
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
1.45
Enterprise Value/Revenue
1.48
Enterprise Value/EBITDA
10.44
Financial Highlights
Profitability and Income Statement
Profit Margin
11.08%
Return on Assets (ttm)
6.05%
Return on Equity (ttm)
11.08%
Revenue (ttm)
3.33B
Net Income Avi to Common (ttm)
368.68M
Diluted EPS (ttm)
0.58
Balance Sheet and Cash Flow
Total Cash (mrq)
892.35M
Total Debt/Equity (mrq)
20.96%
Levered Free Cash Flow (ttm)
429.76M